In this episode of Science Lab, we break down the latest research comparing traditional cigarette smoking with heated tobacco products (HTPs). Using evidence from multiple clinical studies, she explains how switching completely from smoking to HTPs affects biomarkers of exposure, biomarkers of potential harm, reported symptoms, and overall risk profiles.
All content for GFN News is the property of GFN.TV and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of Science Lab, we break down the latest research comparing traditional cigarette smoking with heated tobacco products (HTPs). Using evidence from multiple clinical studies, she explains how switching completely from smoking to HTPs affects biomarkers of exposure, biomarkers of potential harm, reported symptoms, and overall risk profiles.
GFN Insights #9 | POWER, AIRFLOW & TEMPERATURE EXPLAINED! | SCIENCE OF VAPING
GFN News
14 minutes 56 seconds
3 weeks ago
GFN Insights #9 | POWER, AIRFLOW & TEMPERATURE EXPLAINED! | SCIENCE OF VAPING
Discover the real science behind effective vaping.
In this episode, Joanna Junak talks with vaping science researcher Roberto Sussman about how power, airflow, and resistance shape vapor production, flavor, and efficiency. Learn why temperature control isn’t the key factor—and how adjusting wattage, coil resistance, and airflow settings can completely change your vaping experience.
We explore:
🔥 How power affects vapor density and flavor
💨 Why airflow and mouthpiece design matter
⚙️ How resistance acts as a proxy for temperature
🧪 Why understanding these parameters leads to safer, more consistent vaping
If you’ve ever wondered how to tune your vape for better performance, this episode explains the physics behind it all—clearly and scientifically.
GFN News
In this episode of Science Lab, we break down the latest research comparing traditional cigarette smoking with heated tobacco products (HTPs). Using evidence from multiple clinical studies, she explains how switching completely from smoking to HTPs affects biomarkers of exposure, biomarkers of potential harm, reported symptoms, and overall risk profiles.
